Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries Ltd: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Cancer Immunology 2018

About Conference

Cancer Immunology conference slated for October 26-27, 2017, Osaka, Japan deals with the advanced topics related to Cancer Immunology and Tumor Immunology, Cancer and Tumor Diagnosis and therapy, Epidemiology and prevention, Healthcare delivery, Information, patients and the public which will cover the topics like Education and communication about cancer, Public policy issues, ethics and confidentiality Cancer cell and model systems, the tumor microenvironment etc.

The major theme of the conference is “Explore the Possibilities in the Field of Cancer and Tumor”.

Cancer Immunology will mainly target Fellows, nurse practitioners, nurses, physician assistants, researchers, and other health care professionals interested in the treatment of cancer and Tumor. Cancer Immunology conference acts as a bridge between academics and business to offer them a common platform to interact and share ideas.

Why to attend?

With members from around the world focused on learning about Cancer& Tumor immunology and its advances: this is your best opportunity to reach the largest assemblage of participants from Cancer & Tumor immunology community. conduct presentations, distribute information’s, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2 day event, world renowned speakers, the most recent techniques, developments, and the newest updates in  Cancer& Tumor  immunology are hallmarks of this conference.

Target Audience:

  • Immunologists
  • Oncologists
  • Scientists
  • Research Professors
  • Physicians
  • Pharmacists
  • Business Entrepreneurs
  • Medical Colleges
  • Cancer & Tumor research  Students

Scientific Sessions

Track 1: Cancer Immunology:

Cancer immunology will outline the basic biology of immune responses with the goal of developing new immune therapy approaches and improving existing ones. Basic research to investigate, at the cellular and  molecular levels, the mechanisms that regulate the immune system, yielding knowledge that will further our efforts to harness the power of the immune system to treat cancer.

Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC

Related Conferences:  International Conference on Cancer & Tumor Immunology October 26-27, 2017 Osaka, Japan; International Conference on Cancer Biology R&D and Market June 21 - 22, 2017 Philadelphia, USA; USA 8th Molecular Immunology &  Immunogenetics  Congress March 20-21, 2017 Rome, Italy; 2nd International Congress on Contemporary Issues in Women Cancers and Gynaecologic  Oncology Aug 28-29, 2017 London, UK; 9th International Conference on Haematology  November 02-03, 2017 Las Vegas, USA; Cancer Immunology and Immunotherapy Taking a Place in Mainstream Oncology meetings  March 19—23, 2017 Fairmont Chateau Whistler, British Columbia, Canada; 2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference   27 Feb 2017 - 02 Mar 2017 Cancun, Mexico; Haematopoiesis   January 31—February 4, 2017 Fairmont Banff Springs, Banff, Alberta, Canada; Cancer Immunotherapy  conference EMBL Heidelberg, Germany, 2 - 4 Feb 2017 EMBL-cancer Core Europe Conference; 3rd EACR Conference on Cancer Genomics  Cambridge, UK: 25 - 28 June 2017

Track 2: Tumor Immunology:

Tumor Immunology is determining the function and behaviour of innate and adaptive immune cells in health and disease, including the interactions with their microenvironment. Understanding the basic principles underlying immune cell development, activation, regulation, differentiation and death as well as the molecular mechanisms underlying diversity and plasticity of the immune system is a prerequisite for the design of targeted manipulation strategies to protect from cancer, autoimmunity and infection and to foster and devise the development of novel therapeutic approaches. To address their research questions the individual groups develop and use sophisticated experimental model systems and technologies such as structural biology, genetic barcoding and high-throughput single cell analysis platforms.

Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC

Related Conferences:4th Asia Pacific Gastroenterology Cancer Summit, April 28-30, 2017 Singapore;9th International Conference on  Clinical Haematology and Experimental Haematology OCTOBER 16-17, 2017 Rome, Italy; Global Summit on Oncology & Cancer May 25-27, 2017 Osaka, Japan; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; 9th world congress & expo on Immunology conference, Oct 02-04, 2017, Toronto, Canada;25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; Breast Cancer Conference 04 - 06 May 2017, Brussels, Belgium; European Lung Cancer Conference, May 5-8, 2017, Switzerland; 2nd  Paediatric Oncology Conference, June 22-23, 2017 Philadelphia, USA; Paediatric Neuro-Oncology Meeting, Feb 13 2017 London, United Kingdom;

Track 3: Immunology & Immunotherapy:

Covers all areas of immunology including cellular and molecular immunology, immunochemistry, immunogenetics, imaging, mathematical modelling, allergy, transplantation immunology, cancer immunology, clinical immunology and immunological therapies, physiological functioning of the immune system in states of both health and disease, malfunctions of the immune system in immunological disorders and therapies (autoimmune diseases, hypersensitivities, immune deficiency, transplant rejection), the physical, chemical and physiological characteristics of the components of the immune system in vitro, in situ, and in vivo are of prime interest.

Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC

Related Conferences:  Global Experts meeting on Oncology Conference Case Reports Aug 29-31, 2017 London, UK: 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain;3rd World Gynaecologic Oncology Congress, July 20-21, 2017 Chicago, Illinois, USA; International Conference on Epigenetics 2017 Nov 13-15, 2017 Frankfurt; World Congress on Preventive oncology July 20-21, 2017 Chicago, USA; 3rd International Urologic Oncology Conference , June 26-28, 2017 Baltimore: 6th World Oral Cancer Congress of the International Academy of Oral Oncology Meeting May 17 to 20, 2017, Bangalore, India: ; 24th Asia Pacific Cancer meeting , June 22- 24, 2017, Seoul, Korea. Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne: World Congress On Oncology And Its Therapeutic Advances, 4 - 6 September 2017 / Milan, Italy: EMBL-Cancer Core Europe Conference on Cancer Immunotherapy, 2 - 4 Feb 2017, Heidelberg, Germany: 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; Stem Cells and Cancer Gordon Research Conference, February 12-17, 2017, Lucca (Barga), Italy.

Track 4: Inflammation and Cancer:

Prolonged inflammation can damage your body’s healthy cells and tissue, and weaken your immune system, the link between inflammation and cancers, cancers tended to occur at sites of chronic inflammation. Lately, it turned out that acute inflammation contributed to the regression of cancer. Inflammation and innate immunity are important targets in patients with cancer

Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC

Related Conferences: International Conference on Cancer & Tumor Immunology October 26-27, 2017 Osaka, Japan; International Conference on Cancer Biology R&D and Market June 21 - 22, 2017 Philadelphia, USA; USA 8th Molecular Immunology &  Immunogenetics  Congress March 20-21, 2017 Rome, Italy; 2nd International Congress on Contemporary Issues in Women Cancers and Gynaecologic Oncology conference Aug 28-29, 2017 London, UK; 9th International Conference on Haematology  November 02-03, 2017 Las Vegas, USA; Cancer Immunology and Immunotherapy Taking a Place in Mainstream Oncology Conference  March 19—23, 2017 Fairmont Chateau Whistler, British Columbia, Canada; 2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference  27 Feb 2017 - 02 Mar 2017 Cancun, Mexico; Haematopoiesis   January 31—February 4, 2017 Fairmont Banff Springs, Banff, Alberta, Canada; Cancer Immunotherapy EMBL Heidelberg, Germany, 2 - 4 Feb 2017 EMBL-cancer Core Europe Conference; 3rd EACR Conference on Cancer Genomics  Cambridge, UK: 25 - 28 June 2017.

Track 5: Cancer & HIV:

People with HIV/AIDS are at high risk for developing certain cancers, such as Kaposi's sarcoma, non-Hodgkin lymphoma, and cervical cancer. For people with HIV, these three cancers are often called "AIDS-defining conditions. Most types of cancer begin when normal cells begin to change and grow uncontrollably, forming a mass called a tumor. A tumor can be benign (noncancerous) or malignant (cancerous, meaning it can spread to other parts of the body).

Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC

Related Conferences: Global Summit on Oncology & Cancer May 25-27, 2017 Osaka, Japan; 3rd World Gynaecologic Oncology Congress, July 20-21, 2017  Chicago; International Conference on Cancer & Tumor Immunology October 26-27, 2017Osaka, Japan; 19th Euro Congress on Cancer Science and Therapy, July 20-22, 2017 Lisbon, Portugal; Paediatric Neuro-Oncology meeting, Feb 13 2017 London, United Kingdom; 2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference  27 Feb 2017 - 02 Mar 2017 Cancun, Mexico; . Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne; Cancer Immunology and Immunotherapy Taking a Place in Mainstream Oncology  March 19—23, 2017 Fairmont Chateau Whistler, British Columbia, Canada; Breast Cancer Conference 04 - 06 May 2017, Brussels, Belgium; ; Cancer Immunotherapy EMBL Heidelberg, Germany, 2 - 4 Feb 2017 EMBL-cancer Core Europe Conference.

Track 6: Tumor Microenvironment:

Cancers are not just masses of malignant cells but complex ‘rogue’ organs, to which many other cells are recruited and can be corrupted by the transformed cells. Interactions between malignant and non-transformed cells create the tumor microenvironment. Changes of the tumor  microenvironment have been closely correlated to cancer-mediated inflammation.

Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC

Related Conference:2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain;14th Annual Translational Medicine and Oncologists Conference Meet November 28-30, 2016 San Francisco, USA; 3rd World Gynaecologic Oncology Congress, July 20-21, 2017 Chicago, Illinois, USA; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 19th Euro Congress on Cancer Science and Therapy, July 20-22, 2017 Lisbon, Portugal; World Congress on Preventive oncology July 20-21, 2017 Chicago, USA;3rd International Urologic Oncology Conference , June 26-28, 2017 Baltimore; Stem Cells and Cancer meeting Gordon Research Conference, February 12-17, 2017, Lucca (Barga), 6th World Oral Cancer Congress of the International Academy of Oral Oncology May 17 to 20, 2017, Bangalore, India: 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy ; World Congress On  Oncology And Its Therapeutic Advances, 4 - 6 September 2017 / Milan, Italy; EMBL-Cancer Core Europe Conference on Cancer Immunotherapy, 2 - 4 Feb 2017, Heidelberg, Germany;24th Asia Pacific Cancer Conference, June 22- 24, 2017, Seoul, Korea: Italy; Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne.

Track 7: Cancer vaccines:

A cancer vaccine is a vaccine that treats   with existing cancer or prevents development of a cancer. Cancer vaccines are also   known as biological response modifiers. A biological response modifier helps by stimulating or restoring the immune system’s ability to fight infections and disease. The most commonly used side effect of cancer vaccines is inflammation at the site of injection, including redness, pain, swelling, warming of the skin, itchiness, and occasionally a rash. Mainly these vaccines include cell therapy and gene therapy.

Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC

Related Conferences: 9th world congress & expo on Immunology Conference, Oct 02-04, 2017, Toronto, Canada: 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain: 3rd World Gynaecologic Oncology Congress, July 20-21, 2017 Chicago, Illinois, USA: International Conference on Epigenetics 2017 Nov 13-15, 2017 Frankfurt.: World Congress on Preventive oncology July 20-21, 2017 Chicago, USA: 3rd International Urologic Oncology Conference , June 26-28, 2017 Baltimore: 6th World Oral Cancer Congress of the International Academy of Oral Oncology May 17 to 20, 2017, Bangalore, India: ; 24th Asia Pacific Cancer Conference, June 22- 24, 2017, Seoul, Korea. Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne; World Congress On Oncology And Its Therapeutic Advances, 4 - 6 September 2017 / Milan, Italy: EMBL-Cancer Core Europe Conference on Cancer Immunotherapy, 2 - 4 Feb 2017, Heidelberg, Germany: 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy: Stem Cells and Cancer meeting Gordon Research Conference, February 12-17, 2017, Lucca (Barga), Italy. 

Track 8: Cancer prognosis:

Cancer prognosis gives us information about the percentage of people who survive a certain type of cancer for specific amount of time. Some of the factors that affect  prognosis like  type of cancer, its location in the body,  stage, size of the cancer,  cancer’s grade and age of the patients etc… The time of period varies; it may be 1 year, 2 years, 5 years, and etc... Cancer-specific survival is also called as Disease-specific survival. There are different ways to measure and report survival and statistics of cancer. This cancer prognosis that mainly  include liver cancer prognosis, metastatic prognosis and brain cancer prognosis.

Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC

Related Conferences: 9th   International Conference on  Clinical Haematology  and Experimental Haematology October 16-17, 2017 Rome, Italy;  World Congress on Preventive oncology July 20-21, 2017 Chicago, USA; International Conference on Cancer & Tumor Immunology October 26-27, 2017 Osaka,Japan; International Conference on Epigenetics 2017 Nov 13-15, 2017 Frankfurt; 2nd  Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference  27 Feb 2017 - 02 Mar 2017 Cancun, Mexico; 6th World Oral Cancer Congress of the International Academy of Oral Oncology meeting  May 17 to 20, 2017, Bangalore, India; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; ; 24th Asia Pacific Cancer Conference, June 22- 24, 2017, Seoul, Korea. Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne;  Breast Cancer Conference 04 - 06 May 2017, Brussels, Belgium; 2nd International Conference on Pancreatic & Colorectal Cancer and Therapeutics October 16-18, 2017 Baltimore, USA. European  Lung Cancer Conference, May 05- 08 2017, Switzerland.

Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC

Track 9: Cancer Cell Biology:

 Cancer cell biology can be defined as a disease of the genes. This is the small part of DNA and master molecule of the cell. The main two characteristics are uncontrolled growth of the cells in the human body and the ability of these cells to migrate and spread to distant sites. If the spread is not controlled, cancer can result in death. Bone marrow stromal stem cells also called mesenchyme stem cells or skeletal stem cells and these can generate bone, cartilage, and fat cells. The cancer pathology is a medical document that written by a pathologist. A pathologist is a doctor who specializes in interpreting laboratory tests and evaluating cells, tissues, and organs to diagnose disease.

Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC

Related Conferences: International Conference on Cancer & Tumor Immunology October 26-27, 2017 Osaka, Japan  Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK; 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain;3rd World Gynaecologic Oncology Congress, July 20-21, 2017 Chicago, Illinois, USA; International Conference on Epigenetics 2017 Nov 13-15, 2017 Frankfurt; World Congress on Preventive oncology July 20-21, 2017 Chicago, USA; 3rd International Urologic Oncology Conference , June 26-28, 2017 Baltimore: 6th World Oral Cancer Congress of the International Academy of Oral Oncology May 17 to 20, 2017, Bangalore, India ; World Congress on Oncology and Its Therapeutic Advances, 4 - 6 September 2017 / Milan, Italy: EMBL-Cancer Core Europe Conference on Cancer Immunotherapy, 2 - 4 Feb 2017, Heidelberg, Germany: 24th Asia Pacific Cancer Conference, June 22- 24, 2017, Seoul, Korea. Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne; 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; Integrating Metabolism and Immunity, May 29 - June 2, 2017 | Dublin, Ireland.

Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC

Track 10: Tumor biology:

 Cells may acquire mutations in genes that control proliferation, such as tumor suppressor genes. Tumors grow in a series of steps. The first step is hyperplasia, resulting from uncontrolled cell division. These cells appear normal, but some changes occurred that results in loss of control of growth. The second step is dysplasia, resulting from further growth, accompanied by abnormal changes to the cells. The third step requires additional changes, which result in cells that are even more abnormal and can now spread over a wider area of tissue. These cells begin to lose their original function; such cells are called anaplastic. At this stage, the tumor is still contained within its original location (called in situ) and is not invasive, it is not considered malignant - it is potentially malignant. The last step occurs when the cells in the tumor metastasize, which means that they can invade surrounding tissue, including the bloodstream, and spread to other locations. This is the most serious type of tumor, but not all tumors progress to this point. These Tumor Biology that mainly Include Molecular and Cellular oncology and Immuno oncology.

Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC

Related Conferences: International Conference on Epigenetics 2017 Nov 13-15, 2017 Frankfurt; Global Experts meeting on Oncology Case Reports Aug 29-31, 2017 London, UK: 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain;3rd World Gynaecologic Oncology Congress, July 20-21, 2017 Chicago, Illinois, USA; World Congress on Preventive oncology July 20-21, 2017 Chicago, USA; 3rd International Urologic Oncology Conference , June 26-28, 2017 Baltimore;24th Asia Pacific Cancer Conference, June 22- 24, 2017, Seoul, Korea. Lorne Cancer Conference 6th World Oral Cancer Congress of the International Academy of Oral Oncology May 17 to 20, 2017, Bangalore, India; February 9-11th 2017 - Mantra Lorne: EMBL-Cancer Core Europe Conference on Cancer Immunotherapy, 2 - 4 Feb 2017, Heidelberg, Germany: 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; Stem Cells and Cancer Gordon Research Conference, February 12-17, 2017, Lucca (Barga), Italy. World Congress On Oncology And Its Therapeutic Advances, 4 - 6 September 2017 / Milan, Italy;

Track 11: Economic Impact on Cancer:

 Cancer care costs are a financial burden to patients, their families, and society as a whole. In 2006 medical expenses from cancer care in the United States were an estimated $104.1 billion. Cancer  can be a major cause of lack of money. This may be due either to the costs of treating and managing the illness as well as its impact upon people's ability to work. This particularly affects countries that lack comprehensive social health insurance systems and other types of social safety nets. The study is a longitudinal short study of 10,000 hospital patients with a first time diagnosis of cancer. Patients were assigned a socioeconomic status according to the district of residence at diagnosis. Continuity of patients due to cancer living in the most deprived district was compared to survival of patients living in all other districts by model-based period analysis. These major regional socioeconomic inequalities indicate a potential for improving cancer care and survival in Germany. Studies on individual patient data with access to treatment information should be conducted to examine the reasons for these socioeconomic inequalities in cancer survival in more detail.

Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC

Related Conferences:  Global Summit on Oncology & Cancer May 25-27, 2017 Osaka, Japan; 3rd World Gynaecologic Oncology Congress, July 20-21, 2017  Chicago; International Conference on Cancer & Tumor Immunology October 26-27,2017Osaka, Japan; 19th Euro Congress on Cancer Science and Therapy, July 20-22, 2017 Lisbon, Portugal; Paediatric Neuro-Oncology meeting, Feb 13 2017 London, United Kingdom; 2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference  27 Feb 2017 - 02 Mar 2017 Cancun, Mexico;  Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne; Cancer Immunology and Immunotherapy Taking a Place in Mainstream Oncology  March 19—23, 2017 Fairmont Chateau Whistler, British Columbia, Canada; Breast Cancer Conference 04 - 06 May 2017, Brussels, Belgium; ; Cancer Immunotherapy EMBL Heidelberg, Germany, 2 - 4 Feb 2017 EMBL-cancer Core Europe Conference.

Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC

Track 12:Cancer Research:

 The goal of the Cancer Research Program is to make significant improvements in the prevention, early detection, diagnosis and treatment of cancer. Research into the cause of cancer involves many different disciplines including genetics, diet, environmental factors (i.e. chemical carcinogens).  And it will continue to translate basic research findings into clinical applications together with strategic partners, with the National Centre for Tumor Diseases (NCT) and the nationally active German Consortium for Translational Cancer Research (DKTK) playing key roles. The program is also developing new approaches in the fields of cancer genome and epigenome research, metabolic dysfunction, personalized radiation oncology and ion therapy, molecular imaging, neuro-oncology, individualized cancer medicine and health economics.

Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC

Related Conferences:  International Conference on Cancer & Tumor Immunology October 26-27, 2017 Osaka, Japan; International Conference on Cancer Biology R&D and Market June 21 - 22, 2017 Philadelphia, USA; USA 8th Molecular Immunology &  Immunogenetics  Congress March 20-21, 2017 Rome, Italy; 2nd International Congress on Contemporary Issues in Women Cancers and Gynaecologic  Oncology Aug 28-29, 2017 London, UK; 9th International Conference on Haematology  November 02-03, 2017 Las Vegas, USA; Cancer Immunology and Immunotherapy Taking a Place in Mainstream Oncology  March 19—23, 2017 Fairmont Chateau Whistler, British Columbia, Canada; 2nd Exploring DNA Repair Pathways as Targets for Cancer Therapy Conference   27 Feb 2017 - 02 Mar 2017 Cancun, Mexico; Haematopoiesis   January 31—February 4, 2017 Fairmont Banff Springs, Banff, Alberta, Canada; Cancer Immunotherapy EMBL Heidelberg, Germany, 2 - 4 Feb 2017 EMBL-cancer Core Europe Conference; 3rd EACR Conference on Cancer Genomics  Cambridge, UK: 25 - 28 June 2017

Track 13: Immuno-Oncology studies:

 Immuno-oncology therapies activate our immune system, making it able to recognise cancer cells and destroy them. Breast cancer is one of the major cancer types for which new immune-based cancer treatments are currently in development. Lung cancer surgery carries risks, including bleeding and infection. Clinical trials are studies of experimental lung cancer treatments. The immune system is the body’s natural defence system. It is a collection of organs, cells and special molecules that helps protect you from infections, cancer and other diseases. Adult central nervous system tumor is a disease in which abnormal cells form in the tissues of the brain and/or spinal cord. A tumor that starts in another part of the body and spreads to the brain is called a metastatic brain tumor. There are different types of brain and spinal cord tumors such as Astrocytic Tumors, Oligodendroglia Tumors, Mixed Gliomas, Ependymal Tumors, Medulloblastomas, Pineal Parenchymal Tumors, Meningeal Tumors, Germ Cell Tumors and Craniopharyngiom. Advances in Immuno-oncology have given oncologists and their patients reason to be encouraged—the launch of immune checkpoint inhibitors and development of other immunotherapy assets for the treatment of several difficult-to-treat diseases, including metastatic melanoma and non-small cell lung cancer, represents great progress.

Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC

Related Conferences:  9th world congress & expo on Immunology Conference, Oct 02-04, 2017, Toronto, Canada: 2nd Cancer Diagnostics Conference & Expo, May 8-10, 2017 Barcelona, Spain: 3rd World Gynaecologic Oncology Congress, July 20-21, 2017 Chicago, Illinois, USA: International Conference on Epigenetics 2017 Nov 13-15, 2017 Frankfurt.: World Congress on Preventive oncology July 20-21, 2017 Chicago, USA: 3rd International Urologic Oncology Conference , June 26-28, 2017 Baltimore: 6th World Oral Cancer Congress of the International Academy of Oral Oncology May 17 to 20, 2017, Bangalore, India: ; 24th Asia Pacific Cancer Conference, June 22- 24, 2017, Seoul, Korea. Lorne Cancer Conference, February 9-11th 2017 - Mantra Lorne; World Congress On Oncology And Its Therapeutic Advances, 4 - 6 September 2017 / Milan, Italy: EMBL-Cancer Core Europe Conference on Cancer Immunotherapy, 2 - 4 Feb 2017, Heidelberg, Germany: 25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy: Stem Cells and Cancer meeting Gordon Research Conference, February 12-17, 2017, Lucca (Barga), Italy. 

Track 14: Novel Approaches in Cancer & Tumor:

The epidermal growth factor receptor (EGFR) autocrine pathway contributes to a number of processes important to cancer development and progression, including cell proliferation, apoptosis, and angiogenesis. Immunotherapy encompasses several different treatment approaches, each of which has a distinct mechanism of action, and all of which are designed to boost or restore immune function in some manner.  This includes: Monoclonal antibodies, Immune checkpoint inhibitors, Therapeutic Cancer vaccines, cytokines, and other non-specific immunotherapies. And mainly includes Metabolomics in Novel Biomarker Discovery.

Cancer conferences | Cancer Immunology conferences | Immunology Conferences | conference series LLC

Related Conferences: Global Summit on Oncology & Cancer May 25-27, 2017 Osaka, Japan; 4th Asia Pacific Gastroenterology Cancer Summit, April 28-30, 2017 Singapore; 9th International Conference on  Clinical and Experimental Haematology october 16-17, 2017 Rome, Italy; Annual Meeting on Immunology and Immunologist, July 03-05, 2017 Malyasia, Kuala lumpur; 9th world congress & expo on Immunology, Oct 02-04, 2017, Toronto, Canada;25th World Cancer Conference, Oct 19-21, 2017 Rome, Italy; Breast Cancer Conference 04 - 06 May 2017, Brussels, Belgium; European Lung Cancer Conference, May 5-8, 2017, Switzerland; 2nd  Paediatric Oncology Conference, June 22-23, 2017 Philadelphia, USA; Paediatric Neuro-Oncology, Feb 13 2017 London, United Kingdom;

 

Market Analysis

About Conference:

Conference Series LLC delighted to invite you all to attend 10th International Conference on Cancer & Tumor Immunology to be held during October 26-27, 2017 Osaka, Japan with the Theme of “Explore the Possibilities in the Field of Cancer and Tumor” which covers a wide range of critically important sessions from basic research to innovations in the area of Immunology.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Cancer Tumor immunology 2017, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Cancer Tumor Immunology 2017 organizing committee look forward to meet you at Osaka, Japan.

For more details please visit: www.cancerimmunologymeeting.conferenceseries.com

Scope and Importance:

The global market for biological therapies for cancer was worth $37.9 billion in 2009, down from $38 billion in 2008. This number is expected to increase at a compound annual growth rate (CAGR) of 7.2% to reach $53.7 billion in 2014. And for cancer immunotherapies is expected to grow to nearly $67.9 billion by 2018, with a five-year compound annual growth rate (CAGR) of 14.7%. With rising instances of cancer and improving access to healthcare, America is far and away the largest segment in the overall market for cancer immunotherapies and is expected to grow to nearly $30.1 billion by 2018 at present’s analyses of global market trends, with data from 2012 and 2013, and projections of CAGRs through 2018. The global single-cell analysis market is expected to reach USD 3.35 Billion by 2021 from USD 1.45 Billion in 2016 at a CAGR of 18.2%. The global market is broadly classified into product, cell type, technique, application, end-users, and regions. On the basis of technique, the market is segmented into flow cytometry, next-generation sequencing (NGS), polymerase chain reaction (PCR), microscopy, mass spectrometry, and others techniques.

Why in Japan?

Osaka is a designated city in the Kansai region of Japan. It is the capital city of Osaka Prefecture and the largest component of the Keihanshin Metropolitan Area, the second largest metropolitan area in Japan and among the largest in the world with over 19 million inhabitants. Situated at the mouth of the Yodo River on Osaka Bay, Osaka is the second largest city in Japan by daytime population after Tokyo’s 23 wards and the third largest city by night time population after Tokyo’s 23 wards and Yokohama, serving as a major economic hub for the country. Historically a merchant city, Osaka has also been known as the “nation’s kitchen” and served as a center for the rice trade during the Edo period. The city’s west side is open to Osaka Bay, and is otherwise completely surrounded by more than ten satellite cities, all of them in Osaka Prefecture, with one exception: the city of Amagasaki, belonging to Hyōgo Prefecture, in the northwest. The city occupies a larger area than any other city or village within Osaka Prefecture. When the city was established in 1889, it occupied roughly the area known today as the Chuo and Nishi wards, only 15.27 square kilometres that would eventually grow into today’s 222.30 square kilometres (54,932 acres) via incremental expansions, the largest of which being a single 126.01 square kilometres (31,138 acres) expansion in 1925

 Major Associations for Cancer immunology

American Association for Cancer Research, Philadelphia

The American Association of Immunologists- Rockville, USA

International society of stem cell research- Indiana, USA

Association for Cancer Immunotherapy, Germany

Japanese Foundation for Cancer Research, Japan

Major Societies associated with Cancer immunology

Society for Immunotherapy of Cancer- Milwaukee, USA

Clinical Immunology Society -Warsaw, Indiana, USA

The Allergy and Immunology Society of Thailand -Bangkok, Thailand

French Society of Immunology-Paris, France

British Society for Immunology- London, UK

Indian Immunology Society, India

South African Stem Cell Transplantation Society (SA SCTS)-Addis Ababa, Ethiopia

 

Cancer Immunotherapy by Technology Type

Past Conference Report

Tumor & Cancer Immunology 2016

Tumor & Cancer Immunology-2016: Past Conference Report

Conference series LLC hosted the “International Conference on Tumor & Cancer Immunology and Immunotherapy” during July 28-30, 2016 at Holiday Inn Melbourne Airport 10-14 Centre Road, Melbourne Airport, Australia with the theme “Latest Advances in Tumor & Cancer Immunotherapy from Vaccines to Antibodies and Cell Therapies” was a great success, where eminent keynote speakers from various reputed institutions and organizations with their resplendent presence addressed the gathering.

Benevolent response and active participation was received from the renowned experts and Editorial Board Members of Conference series Journals as well as from the Immunologists, Scientists, Researchers, Students and Leaders in Cancer research, Tumor related research field, Immunology, who made this event successful.

The Conference was carried out through various informative and cutting edge sessions, in which the discussions were held on the following thought provoking and cerebrating scientific tracks:

 

·         Tumors

·         Brain Tumors

·         Immune System-Tumors

·         Immunotherapy-Tumors

·         Tumor Immunology

·         Tumor Cells

·         Cancer Vaccines

·         Cancer Immunology & Immunotherapy

·         Immune Checkpoint Inhibitors

·         Cancer Research

·         Combining Cancer Immunotherapies

·         Tumor Immunotherapy Research

·         Cancer Micro and Immuno Environment

·         Tumor Markers and Drug Targeting

·         Tumorigenesis

·         Cancer Clinical Trials

·         Tumor Biology

·         Cancer Biomarkers

·         Immuno-Oncology Studies

·         Immunotherapy Monitoring

·         Antibodies Treatment: Cancer

·         Engineered T-Cell Therapy

·         Novel Approaches

The conference was embarked with an opening ceremony followed by a series of lectures delivered by Honorable Guests and members of the Keynote forum. The adepts who promulgated the theme with their exquisite talk were:

 

·         KN Leung, The Chinese University of Hong Kong, China

·         Jennifer Wu, Hollings Cancer Centre, USA

·         Liang Xu, University of Kansas Cancer Centre, USA

·         Kenichiro Hasumi, Hasumi International Research Foundation, Japan

All the above mentioned Honorable Guests and Keynote speakers gave their energetic and fruitful contributions and special thanks to our Honorable Moderator Takehiko Okamura, for his remarkable contribution towards smooth functioning at Tumor & Cancer Immunology-2016 Conference.

Conference Sessions Chairs:

 

·         Liang Xu, University of Kansas Cancer Centre, USA

·         Dean Mann, Hasumi International Research Foundation, Japan

·         KN Leung, The Chinese University of Hong Kong, China

Best Young Researcher Awards:

 

·         Title: Beyond CTLA-4 and PD-1: Orphan nuclear receptor NR2F6 as T cell signaling switch and emerging target in cancer immunotherapy.

Victoria Klepsch, Medical University Innsbruck, Austria

 

·         Title: Bispecific antibodies in breast cancer immunotherapy, the path forward?

Joanie Del Bano, Aix-Marseille University, France

Conference Series LLC offers its heartfelt appreciation to Societies and Organizations includes Biotechin AsiaTechnology NetworksAllied Academies, Andrew John Publishing Inc., New York Private Equity Forums and is also obliged to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who interlaced with Conference series LLC in supporting and making the conference as never before one.

Your rejoinder is our inspiration; keeping this motto in mind and being witnessed the triumph of Tumor & Cancer Immunology-2016, Conference Series LLC is delighted to announce the next event. Mark your calendars for the upcoming extravaganza, 10th International Conference on Cancer & Tumor Immunology October 26-27, 2017 Osaka,Japan".


Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date July 03-04, 2018

Speaker Opportunity

Supported By

Journal of Cancer Science & Therapy Chemotherapy: Open Access Immunome Research Immunotherapy: Open Access

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by